S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)

Compare Stocks

Date Range: 

 UnitedHealth GroupAnthemCignaHumanaCentene
SymbolNYSE:UNHNYSE:ANTMNYSE:CINYSE:HUMNYSE:CNC
Price Information
Current Price$424.38$393.75$206.63$441.50$64.71
50-Day Moving Average$412.40$376.41$207.14$408.05$63.37
52-Week Low$299.60$269.01$160.37$370.22$57.16
52-Week High$433.50$406.00$272.81$475.44$75.59
MarketRank™
Overall Score3.53.33.82.52.8
Analysis Score3.52.44.41.44.4
Community Score5.04.54.94.45.0
Dividend Score4.24.22.52.50.0
Ownership Score2.53.33.32.52.5
Earnings & Valuation Score2.51.93.81.91.9
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$468.17$421.60$266.65$485.18$82.81
% Upside from Price Target10.32% upside7.07% upside29.05% upside9.89% upside27.97% upside
Trade Information
Market Cap$400.16 billion$96.00 billion$70.28 billion$56.73 billion$37.73 billion
Beta0.771.030.880.890.46
Average Volume2,975,1601,160,3971,870,400903,3883,708,506
Sales & Book Value
Annual Revenue$257.14 billion$121.87 billion$160.40 billion$77.16 billion$111.12 billion
Price / Sales1.560.790.440.740.34
Cashflow$21.24 per share$30.43 per share$26.80 per share$25.82 per share$7.77 per share
Price / Cash19.9812.947.7117.108.33
Book Value$72.28 per share$133.49 per share$139.31 per share$103.73 per share$44.65 per share
Price / Book5.872.951.484.261.45
Profitability
Net Income$15.40 billion$4.57 billion$8.46 billion$3.37 billion$1.81 billion
EPS$16.88$22.48$18.45$18.75$5.00
Trailing P/E Ratio28.0323.139.0723.3453.04
Forward P/E Ratio19.5513.779.0918.0411.33
P/E Growth1.621.070.911.421.01
Net Margins5.33%3.27%4.89%3.09%0.61%
Return on Equity (ROE)22.15%15.24%13.02%13.62%10.39%
Return on Assets (ROA)7.65%5.68%4.09%5.35%3.88%
Dividend
Annual Payout$5.80$4.52$4.00$2.80N/A
Dividend Yield1.37%1.15%1.94%0.63%N/A
Three-Year Dividend Growth68.00%40.74%N/A32.28%N/A
Payout Ratio34.36%20.11%21.68%14.93%N/A
Years of Consecutive Dividend Growth12 Years10 Years1 Years5 YearsN/A
Debt
Debt-to-Equity Ratio0.620.630.650.410.63
Current Ratio0.771.490.501.711.08
Quick Ratio0.771.490.501.711.08
Ownership Information
Institutional Ownership Percentage86.21%86.69%87.06%91.85%91.75%
Insider Ownership Percentage0.55%0.28%0.80%0.40%1.80%
Miscellaneous
Employees2,02083,40073,70048,70071,300
Shares Outstanding942.92 million243.82 million340.11 million128.51 million583.04 million
Next Earnings Date1/19/2022 (Estimated)10/20/2021 (Confirmed)11/4/2021 (Confirmed)11/3/2021 (Confirmed)10/26/2021 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
Centene CNC Investment Analysis - Stock Traders DailyCentene CNC Investment Analysis - Stock Traders Daily
news.stocktradersdaily.com - October 19 at 10:56 AM
Centene Corporation - Consensus Indicates Potential 26.8% Upside - DirectorsTalk InterviewsCentene Corporation - Consensus Indicates Potential 26.8% Upside - DirectorsTalk Interviews
directorstalkinterviews.com - October 19 at 10:56 AM
Zacks: Analysts Expect Centene Co. (NYSE:CNC) to Announce $1.29 EPSZacks: Analysts Expect Centene Co. (NYSE:CNC) to Announce $1.29 EPS
americanbankingnews.com - October 17 at 9:10 PM
First Week of CNC June 2022 Options TradingFirst Week of CNC June 2022 Options Trading
nasdaq.com - October 17 at 9:55 AM
Centene: You May Want This Option - Seeking AlphaCentene: You May Want This Option - Seeking Alpha
seekingalpha.com - October 16 at 7:56 AM
Director Of Centene Makes $210K Sale - BenzingaDirector Of Centene Makes $210K Sale - Benzinga
benzinga.com - October 15 at 12:18 AM
Director Of Centene Makes $210K SaleDirector Of Centene Makes $210K Sale
finance.yahoo.com - October 14 at 7:17 PM
Wayspring Completes $75 Million Funding Round Backed By Valtruis, Centene & More - OPEN MINDS - OPEN MINDSWayspring Completes $75 Million Funding Round Backed By Valtruis, Centene & More - OPEN MINDS - OPEN MINDS
openminds.com - October 14 at 2:17 PM
Insider Selling: Centene Co. (NYSE:CNC) Director Sells 3,300 Shares of StockInsider Selling: Centene Co. (NYSE:CNC) Director Sells 3,300 Shares of Stock
americanbankingnews.com - October 13 at 11:06 PM
Centene Corp. stock falls Tuesday, still outperforms market - MarketWatchCentene Corp. stock falls Tuesday, still outperforms market - MarketWatch
marketwatch.com - October 13 at 1:31 AM
One of Centenes longest-serving board directors steps down after 18 years - KSDK.comOne of Centene's longest-serving board directors steps down after 18 years - KSDK.com
ksdk.com - October 12 at 3:30 PM
World Wide Technologys David Steward retires from Centene board after 18 years - St. Louis Business Journal - St. Louis Business JournalWorld Wide Technology's David Steward retires from Centene board after 18 years - St. Louis Business Journal - St. Louis Business Journal
bizjournals.com - October 10 at 9:10 PM
One of Centenes longest-serving board directors steps down after 18 yearsOne of Centene's longest-serving board directors steps down after 18 years
finance.yahoo.com - October 10 at 9:10 PM
Centene Corporation Announces Retirement of David L. Steward from Board of Directors - marketscreener.comCentene Corporation Announces Retirement of David L. Steward from Board of Directors - marketscreener.com
marketscreener.com - October 10 at 1:12 AM
CENTENE CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - marketscreener.comCENTENE CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - marketscreener.com
marketscreener.com - October 8 at 11:41 PM
David Steward Retires From Centenes Board Of Directors - PRNewswireDavid Steward Retires From Centene's Board Of Directors - PRNewswire
prnewswire.com - October 8 at 11:41 PM
Centene Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatchCentene Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
marketwatch.com - October 8 at 6:39 PM
David Steward Retires From Centenes Board Of Directors - Webster County CitizenDavid Steward Retires From Centene's Board Of Directors - Webster County Citizen
webstercountycitizen.com - October 8 at 6:39 PM
David Steward Retires From Centenes Board Of DirectorsDavid Steward Retires From Centene's Board Of Directors
markets.businessinsider.com - October 8 at 6:07 PM
Pharmacy Benefit Manager Agrees to Pay $15.2 Million to Settle Allegations of Arkansas Medicaid Overbilling - JD SupraPharmacy Benefit Manager Agrees to Pay $15.2 Million to Settle Allegations of Arkansas Medicaid Overbilling - JD Supra
jdsupra.com - October 8 at 1:39 PM
Medicaid department: No emails between DeWine-connected lobbyist and staff - Ohio Capital JournalMedicaid department: No emails between DeWine-connected lobbyist and staff - Ohio Capital Journal
ohiocapitaljournal.com - October 8 at 8:39 AM
Centene Faces Proposed Class Action Alleging Inadequate Network - Bloomberg LawCentene Faces Proposed Class Action Alleging Inadequate Network - Bloomberg Law
news.bloomberglaw.com - October 6 at 2:02 PM
Wellcare Announces Largest Medicare Advantage Expansion to Date - PRNewswireWellcare Announces Largest Medicare Advantage Expansion to Date - PRNewswire
prnewswire.com - October 6 at 2:02 PM
Centene growing Medicare Advantage footprint by 26% in 2022 - Healthcare Finance NewsCentene growing Medicare Advantage footprint by 26% in 2022 - Healthcare Finance News
healthcarefinancenews.com - October 6 at 2:02 PM
Centene Corp. stock falls Monday, still outperforms market - MarketWatchCentene Corp. stock falls Monday, still outperforms market - MarketWatch
marketwatch.com - October 4 at 7:28 PM
DateCompanyBrokerageAction
10/18/2021UnitedHealth GroupBMO Capital Markets
Boost Price Target
10/15/2021UnitedHealth GroupEvercore ISI
Boost Price Target
10/15/2021UnitedHealth GroupMorgan Stanley
Boost Price Target
10/15/2021UnitedHealth GroupRoyal Bank of Canada
Boost Price Target
10/15/2021UnitedHealth GroupCredit Suisse Group
Boost Price Target
10/15/2021UnitedHealth GroupOppenheimer
Boost Price Target
10/11/2021CignaUBS Group
Lower Price Target
9/27/2021UnitedHealth GroupSVB Leerink
Initiated Coverage
9/27/2021AnthemSVB Leerink
Initiated Coverage
9/27/2021CignaSVB Leerink
Initiated Coverage
9/27/2021HumanaSVB Leerink
Initiated Coverage
9/14/2021CenteneCredit Suisse Group
Lower Price Target
9/14/2021CenteneMorgan Stanley
Lower Price Target
9/10/2021CignaBank of America
Downgrade
9/9/2021UnitedHealth GroupCowen
Initiated Coverage
9/9/2021AnthemCowen
Initiated Coverage
9/9/2021CignaCowen
Initiated Coverage
9/9/2021HumanaCowen
Initiated Coverage
9/9/2021HumanaBarclays
Initiated Coverage
9/9/2021CenteneCowen
Initiated Coverage
9/8/2021CenteneMizuho
Lower Price Target
8/31/2021UnitedHealth GroupMorgan Stanley
Lower Price Target
8/31/2021AnthemMorgan Stanley
Boost Price Target
8/31/2021CignaMorgan Stanley
Lower Price Target
8/31/2021HumanaMorgan Stanley
Boost Price Target
8/31/2021CenteneMorgan Stanley
Lower Price Target
8/17/2021CenteneRoth Capital
Initiated Coverage
8/9/2021CignaRaymond James
Lower Price Target
8/6/2021CignaTruist Securities
Lower Price Target
8/6/2021CignaCredit Suisse Group
Lower Price Target
8/6/2021CignaBank of America
Lower Price Target
8/6/2021CignaDeutsche Bank Aktiengesellschaft
Lower Price Target
8/6/2021CignaJefferies Financial Group
Lower Price Target
8/6/2021CignaTruist
Lower Price Target
8/6/2021CignaOppenheimer
Lower Price Target
8/6/2021CignaBMO Capital Markets
Lower Price Target
8/6/2021CignaStephens
Lower Price Target
8/6/2021CignaMizuho
Lower Price Target
8/6/2021CignaCitigroup
Lower Price Target
8/3/2021CenteneWells Fargo & Company
Lower Price Target
7/22/2021AnthemJefferies Financial Group
Boost Price Target
7/22/2021AnthemStephens
Boost Price Target
7/22/2021AnthemBMO Capital Markets
Boost Price Target
7/22/2021AnthemBarclays
Boost Price Target
7/22/2021AnthemCantor Fitzgerald
Boost Price Target
7/22/2021AnthemMizuho
Boost Price Target
7/22/2021AnthemRoyal Bank of Canada
Boost Price Target
7/16/2021UnitedHealth GroupStephens
Boost Price Target
7/16/2021UnitedHealth GroupTruist Securities
Boost Price Target
7/16/2021UnitedHealth GroupTruist
Boost Price Target
7/16/2021UnitedHealth GroupRaymond James
Boost Price Target
7/16/2021UnitedHealth GroupCredit Suisse Group
Boost Price Target
7/16/2021UnitedHealth GroupCitigroup
Boost Price Target
7/16/2021UnitedHealth GroupBarclays
Boost Price Target
7/15/2021UnitedHealth GroupOppenheimer
Reiterated Rating
7/13/2021UnitedHealth GroupDeutsche Bank Aktiengesellschaft
Boost Price Target
7/13/2021CignaDeutsche Bank Aktiengesellschaft
Set Price Target
7/9/2021UnitedHealth GroupSeaport Res Ptn
Reiterated Rating
7/9/2021UnitedHealth GroupSeaport Global Securities
Initiated Coverage
7/9/2021AnthemSeaport Res Ptn
Reiterated Rating
7/9/2021AnthemSeaport Global Securities
Initiated Coverage
7/9/2021HumanaSeaport Res Ptn
Reiterated Rating
7/9/2021HumanaJPMorgan Chase & Co.
Boost Price Target
7/9/2021HumanaSeaport Global Securities
Initiated Coverage
7/9/2021CenteneSeaport Res Ptn
Reiterated Rating
7/9/2021CenteneSeaport Global Securities
Initiated Coverage
7/2/2021AnthemMorgan Stanley
Boost Price Target
6/17/2021CenteneCitigroup
Boost Price Target
6/17/2021CenteneTruist Securities
Boost Price Target
6/17/2021CenteneWells Fargo & Company
Boost Price Target
6/17/2021CenteneOppenheimer
Reiterated Rating
6/17/2021CenteneBMO Capital Markets
Boost Price Target
6/17/2021CenteneMizuho
Boost Price Target
6/10/2021AnthemRoyal Bank of Canada
Downgrade
6/8/2021CenteneBank of America
Boost Price Target
6/3/2021CignaMorgan Stanley
Boost Price Target
6/1/2021UnitedHealth GroupBank of America
Boost Price Target
5/24/2021UnitedHealth GroupWells Fargo & Company
Initiated Coverage
5/24/2021AnthemWells Fargo & Company
Initiated Coverage
5/24/2021CignaWells Fargo & Company
Initiated Coverage
5/24/2021HumanaWells Fargo & Company
Initiated Coverage
5/24/2021CenteneWells Fargo & Company
Initiated Coverage
5/21/2021UnitedHealth GroupTruist Securities
Boost Price Target
5/18/2021UnitedHealth GroupWells Fargo & Company
Initiated Coverage
5/18/2021AnthemWells Fargo & Company
Initiated Coverage
5/18/2021CignaWells Fargo & Company
Initiated Coverage
5/18/2021HumanaWells Fargo & Company
Initiated Coverage
5/18/2021CenteneWells Fargo & Company
Initiated Coverage
5/14/2021CignaRoyal Bank of Canada
Boost Price Target
5/11/2021CenteneBMO Capital Markets
Boost Price Target
5/11/2021CenteneStephens
Upgrade
5/10/2021CignaTruist
Boost Price Target
5/10/2021CignaCredit Suisse Group
Boost Price Target
5/10/2021CignaBMO Capital Markets
Boost Price Target
5/7/2021UnitedHealth GroupMizuho
Boost Price Target
5/6/2021AnthemArgus
Boost Price Target
5/3/2021AnthemMizuho
Boost Price Target
4/29/2021HumanaCitigroup
Boost Price Target
4/29/2021HumanaOppenheimer
Boost Price Target
4/29/2021HumanaMizuho
Boost Price Target
4/28/2021CenteneBMO Capital Markets
Lower Price Target
4/22/2021AnthemTruist
Boost Price Target
4/22/2021AnthemStephens
Boost Price Target
4/22/2021AnthemBMO Capital Markets
Boost Price Target
4/22/2021AnthemRoyal Bank of Canada
Boost Price Target
4/22/2021AnthemBarclays
Boost Price Target
4/20/2021AnthemTruist Securities
Boost Price Target
4/14/2021AnthemTruist
Boost Price Target
3/15/2021CenteneMizuho
Initiated Coverage
3/9/2021CenteneMizuho
Initiated Coverage
1/21/2021CenteneThe Goldman Sachs Group
Initiated Coverage
1/15/2021CenteneJefferies Financial Group
Downgrade
1/6/2021HumanaArgus
Boost Price Target
1/4/2021HumanaRoyal Bank of Canada
Upgrade
11/30/2020HumanaSVB Leerink
Lower Price Target
11/4/2020HumanaSmith Barney Citigroup
Boost Price Target
11/4/2020HumanaCredit Suisse Group
Boost Price Target
11/4/2020HumanaOppenheimer
Boost Price Target
11/4/2020HumanaStephens
Boost Price Target
10/13/2020HumanaTruist
Boost Price Target
10/1/2020HumanaSanford C. Bernstein
Initiated Coverage
10/1/2020HumanaPiper Sandler
Boost Price Target
9/10/2020HumanaDeutsche Bank Aktiengesellschaft
Boost Price Target
8/18/2020HumanaJPMorgan Chase & Co.
Boost Price Target
8/17/2020HumanaRoyal Bank of Canada
Boost Price Target
(Data available from 10/19/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.